Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olena Barbash

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Molecular & Cellular Proteomics : MCP|March 29, 2021
A Chemical Acetylation-Based Mass Spectrometry Platform for Histone Methylation ProfilingFrancesca Zappacosta, Craig D Wagner, Anthony Della Pietra, et al.
Molecular Cell|November 4, 2006
Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complexDouglas I Lin, Olena Barbash, K G Suresh Kumar, et al.
Molecular Cancer Research : MCR|August 25, 2018
"Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic MechanismHitoshi Shiota, Janine E Elya, Artyom A Alekseyenko, et al.
Cancer Research Communications|December 5, 2024
Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical TrialsHailei Zhang, Anna Rutkowska, Antonio González-Martín, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
Molecular and Cellular Biology|September 11, 2013
The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanomaEric K Lee, Zhaorui Lian, Kurt D'Andrea, et al.
Cell Reports|December 21, 2017
PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 ExpressionKelly Chiang, Agnieszka E Zielinska, Abeer M Shaaban, et al.
Epigenetics|March 16, 2012
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylationGlenn S Van Aller, Nicolas Reynoird, Olena Barbash, et al.
Pediatric Blood & Cancer|April 21, 2020
Limited antitumor activity of combined BET and MEK inhibition in neuroblastomaJason R Healy, Lori S Hart, Alexander L Shazad, et al.
Scientific Reports|June 28, 2018
Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicingSarah V Gerhart, Wendy A Kellner, Christine Thompson, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecular & Cellular Proteomics : MCP|March 29, 2021
A Chemical Acetylation-Based Mass Spectrometry Platform for Histone Methylation ProfilingFrancesca Zappacosta, Craig D Wagner, Anthony Della Pietra, et al.
Molecular Cell|November 4, 2006
Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complexDouglas I Lin, Olena Barbash, K G Suresh Kumar, et al.
Molecular Cancer Research : MCR|August 25, 2018
"Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic MechanismHitoshi Shiota, Janine E Elya, Artyom A Alekseyenko, et al.
Cancer Research Communications|December 5, 2024
Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical TrialsHailei Zhang, Anna Rutkowska, Antonio González-Martín, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
Molecular and Cellular Biology|September 11, 2013
The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanomaEric K Lee, Zhaorui Lian, Kurt D'Andrea, et al.
Cell Reports|December 21, 2017
PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 ExpressionKelly Chiang, Agnieszka E Zielinska, Abeer M Shaaban, et al.
Epigenetics|March 16, 2012
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylationGlenn S Van Aller, Nicolas Reynoird, Olena Barbash, et al.
Pediatric Blood & Cancer|April 21, 2020
Limited antitumor activity of combined BET and MEK inhibition in neuroblastomaJason R Healy, Lori S Hart, Alexander L Shazad, et al.
Scientific Reports|June 28, 2018
Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicingSarah V Gerhart, Wendy A Kellner, Christine Thompson, et al.
Pageof 4